Carboxypeptidase E (NF-α1): A new trophic factor in neuroprotection

Neuroscience Bulletin

Volumn 30, Issue 4, 2014, Pages 692-696

  Cheng, Yong ^a   Cawley, Niamh X ^a   Loh, Y Peng ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

carboxypeptidase E; neurodegenerative disease; neuroprotection; NF 1; stress

Indexed keywords

CARBOXYPEPTIDASE H;

ANIMAL; BRAIN; DEGENERATIVE DISEASE; ENZYMOLOGY; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CARBOXYPEPTIDASE H; HUMANS; MICE; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION;

EID: 84905977736     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-013-1430-z     Document Type: Review

References (32)

1. Fricker LD, Snyder SH. Enkephalin convertase: purifi cation and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc Natl Acad Sci U S A 1982, 79: 3886-3890. (Pubitemid 12013561)
2. Hook VY, Eiden LE, Brownstein MJ. A carboxypeptidase processing enzyme for enkephalin precursors. Nature 1982, 295: 341-342. (Pubitemid 12159271)
3. Cawley NX, Wetsel WC, Murthy SR, Park JJ, Pacak K, Loh YP. New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev 2012, 33: 216-253.
4. Cool DR, Normant E, Shen F, Chen HC, Pannell L, Zhang Y, et al. Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpefat mice. Cell 1997, 88: 73-83. (Pubitemid 27180332)
5. Lou H, Kim SK, Zaitsev E, Snell CR, Lu B, Loh YP. Sorting and activity-dependent secretion of BDNF require interaction of a specifi c motif with the sorting receptor carboxypeptidase E. Neuron 2005, 45: 245-255. (Pubitemid 40128118)
6. Lim KC, Tyler CM, Lim ST, Giuliano R, Federoff HJ. Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons. Biochem Biophys Res Commun 2007, 361: 599-604. (Pubitemid 47238028)
7. Park JJ, Cawley NX, Loh YP. A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons. Mol Cell Neurosci 2008, 39: 63-73.
8. Lou H, Park JJ, Cawley NX, Sarcon A, Sun L, Adams T, et al. Carboxypeptidase E cytoplasmic tail mediates localization of synaptic vesicles to the pre-active zone in hypothalamic presynaptic terminals. J Neurochem 2010, 114: 886-896.
9. Jin K, Graham SH, Nagayama T, Goldsmith PC, Greenberg DA, Zhou A, et al. Altered expression of the neuropeptideprocessing enzyme carboxypeptidase E in the rat brain after global ischemia. J Cereb Blood Flow Metab 2001, 21: 1422-1429. (Pubitemid 33117182)
10. Zhou A, Minami M, Zhu X, Bae S, Minthorne J, Lan J, et al. Altered biosynthesis of neuropeptide processing enzyme carboxypeptidase E after brain ischemia: molecular mechanism and implication. J Cereb Blood Flow Metab 2004, 24: 612-622. (Pubitemid 38725365)
11. Koks S, Luuk H, Nelovkov A, Areda T, Vasar E. A screen for genes induced in the amygdaloid area during cat odor exposure. Genes Brain Behav 2004, 3: 80-89. (Pubitemid 38405253)
12. Murthy SR, Thouennon E, Li WS, Cheng Y, Bhupatkar J, Cawley NX, et al. Carboxypeptidase E protects hippocampal neurons during stress in male mice by up-regulating prosurvival BCL2 protein expression. Endocrinology 2013, 154: 3284-3293.
13. Cawley NX, Zhou J, Hill JM, Abebe D, Romboz S, Yanik T, et al. The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral defi cits. Endocrinology 2004, 145: 5807-5819. (Pubitemid 39564622)
14. Coulon M, Wellman CL, Marjara IS, Janczak AM, Zanella AJ. Early adverse experience alters dendritic spine density and gene expression in prefrontal cortex and hippocampus in lambs. Psychoneuroendocrinology 2013, 38: 1112-1121.
15. Woronowicz A, Cawley NX, Chang SY, Koshimizu H, Phillips AW, Xiong ZG, et al. Carboxypeptidase E knockout mice exhibit abnormal dendritic arborization and spine morphology in central nervous system neurons. J Neurosci Res 2010, 88: 64-72.
16. Carrel D, Du Y, Komlos D, Hadzimichalis NM, Kwon M, Wang B, et al. NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 2009, 29: 8248-8258.
17. Woronowicz A, Koshimizu H, Chang SY, Cawley NX, Hill JM, Rodriguiz RM, et al. Absence of carboxypeptidase E leads to adult hippocampal neuronal degeneration and memory defi cits. Hippocampus 2008, 18: 1051-1063.
18. fat/fat mice. Int J Neuropsychopharmacol 2013, 16: 1623-1634.
19. Woronowicz A, Cawley NX, Loh YP. Carbamazepine prevents hippocampal neurodegeneration in mice lacking the neuroprotective protein, carboxypetidase E. Clinic Pharmacol Biopharmaceut 2012, Sl: 002.
20. Cheng Y, Cawley NX, Loh YP. Carboxypeptidase E/NFα1: A new neurotrophic factor against oxidative stress-induced apoptotic cell death mediated by ERK and PI3-K/AKT pathways. PLoS ONE 2013, 8: e71578.
21. Koshimizu H, Senatorov V, Loh YP, Gozes I. Neuroprotective protein and carboxypeptidase E. J Mol Neurosci 2009, 39: 1-8.
22. Murthy SR, Dupart E, Al-Sweel N, Chen A, Cawley NX, Peng Loh Y. Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion. Cancer Lett 2013, 341: 204-213.
23. Pla V, Paco S, Ghezali G, Ciria V, Pozas E, Ferrer I, et al. Secretory sorting receptors carboxypeptidase E and secretogranin III in amyloid beta-associated neural degeneration in Alzheimer's disease. Brain Pathol 2013, 23: 274-284.
24. Counts SE, Perez SE, Ginsberg SD, Mufson EJ. Neuroprotective role for galanin in Alzheimer's disease. EXS 2010, 102: 143-162.
25. Cheng Y, Yu LC. Galanin protects amyloid-beta-induced neurotoxicity on primary cultured hippocampal neurons of rats. J Alzheimers Dis 2010, 20: 1143-1157.
26. Weber SJ, Louis RB, Trombley L, Bissette G, Davies P, Davis TP. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease. J Gerontol 1992, 47: B18-25.
27. Stahl S, Reinders Y, Asan E, Mothes W, Conzelmann E, Sickmann A, et al. Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes. Biochim Biophys Acta 2007, 1774: 1237-1246.
28. Mazon Pelaez I, Vogler S, Strauss U, Wernhoff P, Pahnke J, Brockmann G, et al. Identifi cation of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease. Hum Mol Genet 2005, 14: 1977-1989. (Pubitemid 41418034)
29. Ibrahim SM, Mix E, Bottcher T, Koczan D, Gold R, Rolfs A, et al. Gene expression profi ling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 2001, 124: 1927-1938. (Pubitemid 32945894)
30. Lee C, Hu J, Ralls S, Kitamura T, Loh YP, Yang Y, et al. The molecular profi les of neural stem cell niche in the adult subventricular zone. PLoS One 2012, 7: e50501.
31. Skalka N, Caspi M, Caspi E, Loh YP, Rosin-Arbesfeld R. Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway. Oncogene 2013, 32: 2836-2847.
32. Lin LF, Liao MJ, Xue XY, Zhang W, Yan L, Cai L, et al. Combination of Abeta clearance and neurotrophic factors as a potential treatment for Alzheimer's disease. Neurosci Bull 2013, 29: 111-120.